Jakarta, ThedailydID – ERHA Skincare Group has reinforced its position as a leader in Indonesia’s dermatological skincare market with the launch of three clinically driven product innovations. Announced during a media gathering in Jakarta on February 15, 2026, the company introduced ERHA SKINSITIVE Ultracalm Face Sunscreen, ERHA ACNEACT Micellar Water, and HisErha Duo Premium Perfume as part of its strategy to strengthen its dermatology-focused portfolio.
The launch comes amid rapid growth in Southeast Asia’s dermatological skincare market. The sector was valued at US$1.52 billion in 2025 and is projected to reach US$2.29 billion by 2030, reflecting an average annual growth rate of 8.54%. Indonesia plays a central role in this expansion, accounting for roughly 43.5% of the region’s sensitive skincare market.
Domestically, Indonesia’s overall skincare industry is expected to grow to US$4.64 billion by 2032. Against this backdrop, ERHA reaffirmed its commitment as an Indonesian dermatological skincare brand that has consistently delivered clinic-based skin solutions for more than 25 years.
According to Afril Wibisono, Director of Brand, Marketing, and Sales at ERHA, the company is focused on setting industry standards rather than simply following trends. He said the three new products further strengthen ERHA’s role as a pioneer in dermatological skincare developed from real clinical practice rather than marketing claims.
All new innovations are built on ERHA’s “Clinically Created, Dermatologist Trusted” approach, which distinguishes the brand in an industry crowded with products labeled as “dermatologist-tested” or “dermatologist-recommended.” This framework emphasizes that ERHA products are developed directly within clinical environments under strict medical standards.
The company’s formulations are designed through pharmaceutical-grade research and are created by dermatology professionals, with a focus on delivering solutions that are effective, safe, and aligned with the evolving needs of Indonesian consumers who increasingly prioritize science-based skincare.
Through these latest product launches, ERHA aims to strengthen its contribution to the development of Indonesia’s dermatological skincare industry while responding to growing market demand. The move forms part of the company’s long-term strategy to sustain its leadership in clinically driven skincare solutions.
